168 related articles for article (PubMed ID: 20609213)
21. Independent evolution of an antiviral TRIMCyp in rhesus macaques.
Wilson SJ; Webb BL; Ylinen LM; Verschoor E; Heeney JL; Towers GJ
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3557-62. PubMed ID: 18287035
[TBL] [Abstract][Full Text] [Related]
22. Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities.
Carthagena L; Parise MC; Ringeard M; Chelbi-Alix MK; Hazan U; Nisole S
Retrovirology; 2008 Jul; 5():59. PubMed ID: 18613956
[TBL] [Abstract][Full Text] [Related]
23. Geographical, genetic and functional diversity of antiretroviral host factor TRIMCyp in cynomolgus macaque (Macaca fascicularis).
Saito A; Kono K; Nomaguchi M; Yasutomi Y; Adachi A; Shioda T; Akari H; Nakayama EE
J Gen Virol; 2012 Mar; 93(Pt 3):594-602. PubMed ID: 22113010
[TBL] [Abstract][Full Text] [Related]
24. The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α.
Miyamoto T; Nakayama EE; Yokoyama M; Ibe S; Takehara S; Kono K; Yokomaku Y; Pizzato M; Luban J; Sugiura W; Sato H; Shioda T
PLoS One; 2012; 7(10):e47757. PubMed ID: 23094081
[TBL] [Abstract][Full Text] [Related]
25. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.
Yap MW; Dodding MP; Stoye JP
J Virol; 2006 Apr; 80(8):4061-7. PubMed ID: 16571822
[TBL] [Abstract][Full Text] [Related]
26. TRIM5 is an innate immune sensor for the retrovirus capsid lattice.
Pertel T; Hausmann S; Morger D; Züger S; Guerra J; Lascano J; Reinhard C; Santoni FA; Uchil PD; Chatel L; Bisiaux A; Albert ML; Strambio-De-Castillia C; Mothes W; Pizzato M; Grütter MG; Luban J
Nature; 2011 Apr; 472(7343):361-5. PubMed ID: 21512573
[TBL] [Abstract][Full Text] [Related]
27. Enhanced Transduction of
Sii-Felice K; Castillo Padilla J; Relouzat F; Cheuzeville J; Tantawet S; Maouche L; Le Grand R; Leboulch P; Payen E
Hum Gene Ther; 2019 Oct; 30(10):1306-1323. PubMed ID: 30848170
[TBL] [Abstract][Full Text] [Related]
28. Evolution of a TRIM5-CypA splice isoform in old world monkeys.
Newman RM; Hall L; Kirmaier A; Pozzi LA; Pery E; Farzan M; O'Neil SP; Johnson W
PLoS Pathog; 2008 Feb; 4(2):e1000003. PubMed ID: 18389077
[TBL] [Abstract][Full Text] [Related]
29. Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications.
Saito A; Nomaguchi M; Iijima S; Kuroishi A; Yoshida T; Lee YJ; Hayakawa T; Kono K; Nakayama EE; Shioda T; Yasutomi Y; Adachi A; Matano T; Akari H
Microbes Infect; 2011 Jan; 13(1):58-64. PubMed ID: 20955815
[TBL] [Abstract][Full Text] [Related]
30. TRIM5 genotypes in cynomolgus monkeys primarily influence inter-individual diversity in susceptibility to monkey-tropic human immunodeficiency virus type 1.
Saito A; Nomaguchi M; Kono K; Iwatani Y; Yokoyama M; Yasutomi Y; Sato H; Shioda T; Sugiura W; Matano T; Adachi A; Nakayama EE; Akari H
J Gen Virol; 2013 Jun; 94(Pt 6):1318-1324. PubMed ID: 23486671
[TBL] [Abstract][Full Text] [Related]
31. Potent inhibition of HIV-1 by TRIM5-cyclophilin fusion proteins engineered from human components.
Neagu MR; Ziegler P; Pertel T; Strambio-De-Castillia C; Grütter C; Martinetti G; Mazzucchelli L; Grütter M; Manz MG; Luban J
J Clin Invest; 2009 Oct; 119(10):3035-47. PubMed ID: 19741300
[TBL] [Abstract][Full Text] [Related]
32. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro.
Black LR; Aiken C
J Virol; 2010 Jul; 84(13):6564-9. PubMed ID: 20410272
[TBL] [Abstract][Full Text] [Related]
33. TRIM5α restriction affects clinical outcome and disease progression in simian immunodeficiency virus-infected rhesus macaques.
Wu F; Ourmanov I; Riddick N; Matsuda K; Whitted S; Plishka RJ; Buckler-White A; Starost MF; Hirsch VM
J Virol; 2015 Feb; 89(4):2233-40. PubMed ID: 25473059
[TBL] [Abstract][Full Text] [Related]
34. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
Hulme AE; Kelley Z; Okocha EA; Hope TJ
J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
[TBL] [Abstract][Full Text] [Related]
35. Amino acid alterations in Gag that confer the ability to grow in simian cells on HIV-1 are located at a narrow CA region.
Nagao T; Hatcho K; Doi N; Fujiwara S; Adachi A; Nomaguchi M
J Med Invest; 2009 Feb; 56(1-2):21-5. PubMed ID: 19262010
[TBL] [Abstract][Full Text] [Related]
36. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
Sastri J; Campbell EM
AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
[TBL] [Abstract][Full Text] [Related]
37. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.
Berthoux L; Sebastian S; Sokolskaja E; Luban J
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14849-53. PubMed ID: 16203999
[TBL] [Abstract][Full Text] [Related]
38. A naturally occurring single amino acid substitution in human TRIM5α linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection.
Nakayama EE; Nakajima T; Kaur G; Mimaya JI; Terunuma H; Mehra N; Kimura A; Shioda T
AIDS Res Hum Retroviruses; 2013 Jun; 29(6):919-24. PubMed ID: 23379364
[TBL] [Abstract][Full Text] [Related]
39. The hypervariable HIV-1 capsid protein residues comprise HLA-driven CD8+ T-cell escape mutations and covarying HLA-independent polymorphisms.
Crawford H; Matthews PC; Schaefer M; Carlson JM; Leslie A; Kilembe W; Allen S; Ndung'u T; Heckerman D; Hunter E; Goulder PJ
J Virol; 2011 Feb; 85(3):1384-90. PubMed ID: 21106744
[TBL] [Abstract][Full Text] [Related]
40. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.
Briones MS; Dobard CW; Chow SA
J Virol; 2010 May; 84(10):5181-90. PubMed ID: 20219923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
